Tech Company Financing Transactions

Genespire Funding Round

Genespire closed a $52 million Series B investment round on 9/25/2024. Backers included CDP Venture Capital, Sofinnova Partners and XGen Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Via Visconti di Modrone, 18
Milano, 20122
Italy

Phone

Undisclosed

Website

www.genespire.com

Email Address

[email protected]

Overview

At Genespire, we develop off-the-shelf gene therapies. Our proprietary immune shielded lentiviral vectors (ISLV) are designed to allow life-long production of a therapy directly from a patient's liver, offering a one-time treatment for adults and children with genetic diseases. Genespire is led by an experienced and international management team with experience from renowned biotech companies and world-class biopharmaceutical organizations.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Karen Aiach-Pignet

        

Co-Founder

Alessio Cantore

        

Co-Founder

Luigi Naldini

        

VP - Bus. Development

Julianne Smith

        

Browse more venture capital transactions:

Prev: 9/25/2024: Whatfix venture capital transaction
Next: 9/25/2024: Outgo venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document funding rounds that are announced publicly. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary